Urinary Aquaporin 2 Excretion After Methylprednisolone in Fasting Healthy Humans

Regional Hospital Holstebro

Status and phase: Completed; Phase 4

Conditions: Healthy

Treatments: Drug: Methylprednisolone

Study type: Interventional

Funder types: Other

Identifiers

NCT00281710

MED.RES.HOS.2005.02.TGK

Details and patient eligibility

About

We wanted to test the hypotheses that methylprednisolone up regulates u-AQP-2 in fasting healthy humans

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• (1) Genders; both mal and female
• (2) Age; 18- 65 years old
• (3) BMI; below 30
• (4) Females had to bee in oral contraceptive treatment

Exclusion criteria

• (1) Clinical signs or history of disease in the heart, lungs, kidneys or endocrine organs
• (2) Abnormal laboratory test (blood haemoglobin, white cell count, platelets, plasma sodium, plasma potassium, plasma creatinine, plasma albumin, plasma bilirubin, plasma alanine aminotransferase, plasma cholesterol and blood glucose)
• (3) Albuminuria or glucosuria
• (4) Cancer
• (5) Arterial hypertension
• (6) Alcohol abuse
• (7) Use of tobacco
• (8) Medical treatment, except oral contraceptives
• (9) Pregnancy or breast feeding
• (10) Medicine abuse
• (11) Donation of blood less than 1 month before the study.